2024-03-31
0000078003
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-03-31
0000078003
us-gaap:ParentMember
2024-03-31
0000078003
us-gaap:NoncontrollingInterestMember
2024-03-31
0000078003
2024-03-31
0000078003
us-gaap:AccountsReceivableMember
2025-03-30
0000078003
us-gaap:AccountsReceivableMember
2024-12-31
0000078003
us-gaap:OtherCurrentLiabilitiesMember
2025-03-30
0000078003
us-gaap:OtherCurrentLiabilitiesMember
2024-12-31
0000078003
us-gaap:OtherNoncurrentLiabilitiesMember
2025-03-30
0000078003
us-gaap:OtherNoncurrentLiabilitiesMember
2024-12-31
0000078003
pfe:BlackstoneMember
2025-03-01
2025-03-30
0000078003
pfe:ClinicalTrialAgreementTermsMember
pfe:BlackstoneMember
2025-03-30
0000078003
pfe:ApprovalBasedPaymentPeriodMember
pfe:BlackstoneMember
srt:MinimumMember
2025-03-30
0000078003
pfe:ApprovalBasedPaymentPeriodMember
pfe:BlackstoneMember
srt:MaximumMember
2025-03-30
0000078003
pfe:NetSalesAndRoyaltyAgreementTermsMember
pfe:BlackstoneMember
2025-03-30
0000078003
pfe:NetSalesAndRoyaltyAgreementTermsMember
pfe:BlackstoneMember
srt:MinimumMember
2025-03-30
0000078003
pfe:NetSalesAndRoyaltyAgreementTermsMember
pfe:BlackstoneMember
srt:MaximumMember
2025-03-30
0000078003
pfe:RealigningOurCostBaseProgramInitialPhaseMember
2025-03-30
0000078003
pfe:RealigningOurCostBaseProgramInitialPhaseMember
pfe:BiopharmaSegmentMember
2025-03-30
0000078003
us-gaap:OtherRestructuringMember
pfe:RealigningOurCostBaseProgramSellingInformationalAndAdministrativeInitiativeMember
us-gaap:SubsequentEventMember
2025-05-05
0000078003
us-gaap:OtherRestructuringMember
pfe:RealigningOurCostBaseProgramSellingInformationalAndAdministrativeInitiativeMember
us-gaap:SubsequentEventMember
pfe:BiopharmaSegmentMember
2025-05-05
0000078003
us-gaap:OtherRestructuringMember
pfe:RealigningOurCostBaseProgramResearchAndDevelopmentMember
pfe:BiopharmaSegmentMember
2025-03-30
0000078003
pfe:RealigningOurCostBaseProgramMember
us-gaap:SubsequentEventMember
2025-05-05
0000078003
pfe:RealigningOurCostBaseProgramMember
us-gaap:SubsequentEventMember
pfe:BiopharmaSegmentMember
2025-05-05
0000078003
pfe:RealigningOurCostBaseProgramMember
2025-03-30
0000078003
pfe:RealigningOurCostBaseProgramMember
pfe:BiopharmaSegmentMember
2025-03-30
0000078003
pfe:RealigningOurCostBaseProgramMember
pfe:BiopharmaSegmentMember
2023-10-02
2025-03-30
0000078003
pfe:ManufacturingOptimizationProgramPhaseOneMember
pfe:BiopharmaSegmentMember
2025-03-30
0000078003
pfe:ManufacturingOptimizationProgramMember
pfe:BiopharmaSegmentMember
2025-03-30
0000078003
us-gaap:OtherNonoperatingIncomeExpenseMember
2025-01-01
2025-03-30
0000078003
us-gaap:OtherNonoperatingIncomeExpenseMember
2024-01-01
2024-03-31
0000078003
us-gaap:CostOfSalesMember
2025-01-01
2025-03-30
0000078003
us-gaap:CostOfSalesMember
2024-01-01
2024-03-31
0000078003
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2025-01-01
2025-03-30
0000078003
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2024-01-01
2024-03-31
0000078003
us-